Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gerrie Steursma"'
Autor:
Annemiek M E Walenkamp, Janine Nuver, Sanne B. Schagen, Sandra E. Rakers, Rients Huitema, Andrea T Meuleman, Jan W Donkerbroek, Lara M. Kruyt, Erwin M. Wiegman, Jourik A. Gietema, Johannes Stelwagen, Marianne A A de Jong, Gerrie Steursma, Coby Meijer, Alfons C.M. van den Bergh, Igle J. de Jong, Joop D. Lefrandt, Joost A Agelink van Rentergem, Sjoukje Lubberts
Publikováno v:
Cancers, 13(22):5675. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(22):5675. MDPI AG
Cancers, Vol 13, Iss 5675, p 5675 (2021)
Cancers
Volume 13
Issue 22
Cancers, 13(22):5675. MDPI AG
Cancers, Vol 13, Iss 5675, p 5675 (2021)
Cancers
Volume 13
Issue 22
Background: Impaired cognition can be a late effect after treatment in long-term testicular cancer (TC) survivors, negatively affecting their daily life. However, little data is available beyond 20 years post-treatment. We assessed cognitive impairme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c64d04abfeb0d074ac7f3825b5b7d98
http://www.scopus.com/inward/record.url?scp=85118850949&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85118850949&partnerID=8YFLogxK
Autor:
Lara M. Kruyt, Arie M. van Roon, Saskia van de Zande, Christine Eulenburg, Sjoukje Lubberts, Joop D. Lefrandt, Jan Willem Donkerbroek, Igle J. de Jong, Coby Meijer, Anne I. van Gessel, Gerrie Steursma, Janine Nuver, Lars C Steggink, Jourik A. Gietema, Sjoukje F. Oosting, Annemiek M E Walenkamp, Johannes Stelwagen
Publikováno v:
British Journal of Cancer, 1599-1607. Nature Publishing Group
ISSUE=11;STARTPAGE=1599;ENDPAGE=1607;ISSN=0007-0920;TITLE=British Journal of Cancer
British Journal of Cancer, 123(11), 1599-1607. Nature Publishing Group
British Journal of Cancer
ISSUE=11;STARTPAGE=1599;ENDPAGE=1607;ISSN=0007-0920;TITLE=British Journal of Cancer
British Journal of Cancer, 123(11), 1599-1607. Nature Publishing Group
British Journal of Cancer
Background Late effects of cisplatin-based chemotherapy in testicular cancer survivors (TCS) include cardiovascular morbidity, but little data is available beyond 20 years. The objective was to assess vascular damage in very long-term TCS. Methods TC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7a97ec60429ef94a56f0f113d483b03
https://research.rug.nl/en/publications/47e16914-eac5-4b43-8e28-529da63f79bf
https://research.rug.nl/en/publications/47e16914-eac5-4b43-8e28-529da63f79bf
Autor:
Igle J. de Jong, Wim J. Sluiter, Sjoukje F. Oosting, Lara M. Kruyt, Janine Nuver, Robert J. van Ginkel, Lars C Steggink, Sjoukje Lubberts, Jourik A. Gietema, Christine Eulenburg, Joop D. Lefrandt, Gerrie Steursma, Coby Meijer
Publikováno v:
Journal of Clinical Oncology. 35:4550-4550
4550 Background: Four decades have passed since the introduction of cisplatin-based chemotherapy for metastatic TC, providing the opportunity to evaluate very long-term survival. Although 80-90% of the patients are cured, the effect of treatment on r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f08dee6deaca0633e74790b00e73bd8e
https://doi.org/10.1200/jco.2017.35.15_suppl.4550
https://doi.org/10.1200/jco.2017.35.15_suppl.4550
Autor:
Jourik A. Gietema, Janine Nuver, Sjoukje Lubberts, Joop D. Lefrandt, Sophie Bunskoek, Sabine Siesling, Wim J. Sluiter, Gerrie Steursma, Annette J. Berendsen, Hink Boer
Publikováno v:
Journal of Clinical Oncology. 35:4561-4561
4561 Background: Testicular cancer (TC) survivors are at risk to develop early cardiovascular morbidity. Close collaboration between oncologists and primary care physicians (PCPs) is mandatory for optimal cardiovascular risk management. We designed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16d9281d340f64828910512960de5188
https://doi.org/10.1200/jco.2017.35.15_suppl.4561
https://doi.org/10.1200/jco.2017.35.15_suppl.4561